Pharma investigated by Poland's Justice Dept

4 June 2006

An investigation into allegations of corrupt practices by drugmakers in Poland has been ordered by the country's Justice Minister, Zbigniew Ziobro. The move was announced in local media following a complaint against Swiss drug major Roche's Polish subsidiary. The firm was alleged to have recommended offering cash and holiday inducements to doctors in exchange for increased prescription of drugs at a training session for local sales representatives.

The Justice Ministry issued a statement saying that "practices employed by the Roche group could involve signs of corruption." Ewa Grenda, Roche's general director for Poland, issued a firm denial of wrongdoing, telling the Polish daily newspaper Gazeta Wyborzca: "the examples used by participants in training were not directives, nor plans, nor recommendations of the attitude people should have to sales."

State reimbursement levels falling

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight